Glass Health vs PaceMate
PaceMate sells to cardiac device clinics. Auto-Triage ranks remote monitoring alerts, and the vendor claims a 61% cut in physician alert burden and a 73% cut in loop recorder false-positive alerts. PaceMate states bi-directional links to Epic, Oracle Health and athenahealth, plus ISO/IEC 27001:2022, HITRUST r2, SOC 2 Type 2, SOC 3 and HIPAA with a BAA. Its four tiers, Software, Flexible, Premium and Elite, carry no amounts. An alert-triage platform for cardiac device clinics answers a different need from a clinician's scribe, and Glass sits outside that evaluation. The one openFDA record bearing the PaceMate name is a 1990 thermal dilution catheter from another company.
Glass Health is bought one clinician at a time. The company was founded in 2021 and raised a $5M seed led by Initialized Capital. Its practices page states HIPAA-compliant infrastructure and BAAs and says nothing on SOC 2 or HITRUST. EHR workflows sit on the $200 per month Max tier.
Decision support · Reviewed November 2, 2026
Glass Health
by Glass Health · founded 2021
DDx plus literature-grounded A&P plus ambient scribe in one workflow.
PaceMate
by PaceMate
Cardiac device remote monitoring platform whose Auto-Triage ranks device alerts by clinical priority for device clinics.
When to pick each one
Glass Health
- Founded 2021, $5M seed led by Initialized Capital
- BAA offered, HIPAA-compliant infrastructure stated
PaceMate
- Auto-Triage ranks device alerts by clinical priority
- Vendor states bi-directional Epic, Oracle Health, athenahealth links
- ISO 27001, HITRUST r2 and SOC 2 Type 2 stated
Score
Each row shows points earned of points available under the published rubric.
Glass Health
42of 100
PaceMate
47of 100
| Dimension | Glass Health | PaceMate | Difference |
|---|---|---|---|
| FDA clearance | 0 / 12 | 0 / 12 | 0 |
| HIPAA / SOC2 / BAA | 6 / 10 | 10 / 10 | -4 |
| EHR integrations (count) | 2.8 / 5.6 | 1.7 / 5.6 | +1.1 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 3.4 / 4.8 | 4.8 / 4.8 | -1.4 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 8.4 / 21 | 14.7 / 21 | -6.3 |
| RCT / meta-analysis / systematic review | 0 / 9 | 4.5 / 9 | -4.5 |
| Funding & adoption signal | 8.4 / 12 | 3 / 12 | +5.4 |
| Pricing transparency | 2.5 / 2.5 | 1.3 / 2.5 | +1.3 |
| Years in market | 4.2 / 6 | 0 / 6 | +4.2 |
Scroll horizontally to see every column.
Pricing
Glass Health
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Lite | n/a | n/a | Limited scribing and clinical decision support. Carries ad sponsorships. |
| Starter | $20 | n/a | Carries ad sponsorships. |
| Pro | $90 | n/a | Most popular tier, ad-free. |
| Max | $200 | n/a | For clinics. EHR integration (Athena, Epic, eCW, Elation) is available only on this tier. |
PaceMate
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
Glass Health
FDA decisions
No FDA decision cited in our research as of October 26, 2026.
Peer-reviewed
1 PubMed record names Glass Health.
Community
1 post sourced: 0 positive, 1 neutral, 0 negative.
PaceMate
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Peer-reviewed
3 PubMed records name PaceMate.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Glass Health | PaceMate |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Epic, athenahealth, eClinicalWorks, Elation | Epic, Oracle Health, athenahealth |
| Founded | 2021 | n/a |
| HQ | US | n/a |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.